References
- Chen, C.T., Hung, H.M.J., Hsiao, C.F. (2012). Design and evaluation of multi-regional trials with heterogeneous treatment effect across regions. Journal of Biopharmaceutical Statistic, 22(5):1037-1050.
- Chiang, C., Hsiao, C.F. (2019). Use of interval estimations in design and evaluation of multi-regional clinical trials with continuous outcomes. Statistical Methods in Medical Research, 28(7):2179-2195.
- DerSimonia, R., Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177-188.
- DIA China Digital Health Community. (2020). The impact of the pandemic on clinical trials and the results of a survey of digital technology needs. China: DIA subscription.
- EMA (2020). Guidance on the management of clinical trials during the COVID-19 (Coronavirus) pandemic. Available at: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf. Accessed on June 12, 2020.
- Hartung, J. (1999). An alternative method for meta-analysis. Biometrical Journal 41(8), 901-916.
- Huang, C., Wang, Y., Li, X., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223), 497-506.
- Jordan, R. E., Adab, P., and Cheng, K. K. (2020), Covid-19: risk factors for severe disease and death. BMJ, 368:m1198, DOI: 10.1136/bmj.m1198.
- Melhem, F. (2020). The global impact of COVID-19 on clinical trials and the way forward. Industry Insight. Available at: https://www.technologynetworks.com/drug-discovery/blog/the-global-impact-of-covid-19-on-clinical-trials-and-the-way-forward-333652. Accessed on June 12, 2020.
- Meyer, R.D., et al. (2020). Statistical issues and recommendations for clinical trials conducted during the COVID-19 pandemic. Statistics in Biopharmaceutical Research https://doi.org/10.1080/19466315.2020.1779122.
- Miseta, E. (2020). COVID-19 and its impact on clinical trials. Clinical Leader. Available at: https://www.clinicalleader.com/doc/covid-and-its-impact-on-clinical-trials-0001. Accessed on June 12, 2020.
- Nature Research Custom Media. (2020). AI lends speed and precision in the urgent search for new drugs with the help of big data and artificial intelligence, clinical trials are managed with greater efficiency and precision. Available at: https://www.nature.com/articles/d42473-020-00093-0. Accessed on June 12, 2020.
- Pfefferbaum, B., and North, C. S. (2020). Mental health and the Covid-19 pandemic. New England Journal of Medicine, DOI: 10.1056/NEJMp2008017.
- US FDA. (2020). Guidance on conduct of clinical trial of medical products during COVID-19 pandemic. Available at: https://www.fda.gov/media/136238/download. Accessed on June 12, 2020.
- Webster, P. (2020). Virtual health care in the era of COVID-19. The Lancet 395(10231), 1180-1181. DOI: 10.1016/S0140-6736(20)30818-7.
- Whitehead A. (2002). Meta-analysis of Controlled Clinical Trials. New York: Wiley.
- Zhu, N., Zhang, D., Wang, W., et al. (2020). A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382,727-733.